Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Number of holders
-
143
-
Total shares
-
5.29M
-
Shares change
-
-533K
-
Total reported value, excl. options
-
$373M
-
Value change
-
-$36.5M
-
Number of buys
-
59
-
Number of sells
-
-54
-
Price
-
$70.61
Significant Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q3 2024
filings reported holding IHE - ISHARES TR - U.S. PHARMA ETF as of Q3 2024.
ISHARES TR - U.S. PHARMA ETF (IHE) has 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.29M shares
.
Largest 10 shareholders include Fisher Asset Management, LLC (3.35M shares), MORGAN STANLEY (227K shares), Rockport Wealth LLC (206K shares), BANK OF AMERICA CORP /DE/ (155K shares), BROWN ADVISORY INC (94.4K shares), LPL Financial LLC (90.4K shares), Royal Bank of Canada (87.1K shares), GOLDMAN SACHS GROUP INC (70.6K shares), WELLS FARGO & COMPANY/MN (61.4K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (48.3K shares).
This table shows the top 143 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.